Saint Peter's joins the growing network of Accelitech partners
Chicago (PRWEB) February 22, 2010
Accelitech LLC announces the commencement of patient treatments at it’s new CyberKnife program located in New Brunswick, NJ, a hospital-based facility operated by Saint Peter’s University Hospital. The acquisition and deployment of the CyberKnife was made possible through a joint venture partnership created by Accelitech. This is the second joint venture of this kind in New Jersey that Accelitech has implemented.
The Accelitech partnership with St. Peter’s joins its other CyberKnife partners including the Hospital of Saint Raphael’s (Connecticut), Cooper University Hospital (New Jersey), Mercy Hospital (Miami), Lafayette General Medical Center (Louisiana), Penrose – St. Francis (Colorado Springs) and Saint Elizabeth’s Regional Medical Center (Nebraska). The Accelitech network continues to grow giving partner’s greater access to leading business and clinical practices for building stereotactic radiosurgery programs. “With increasing market competition throughout the US, Accelitech brings to its hospital partners the experience that makes the difference between success and failure in a given market”, says Jim TeWinkle, Executive Vice President of Accelitech “Simply having the technology is no longer enough. Physician alignment, clinical experience, marketing and operational efficiency are key”.
The proprietary Accelitech model allows hospitals to secure advanced technology that they might not otherwise be able to provide to their patients and physicians. With a full array of support services, the Accelitech Model helps hospitals and physicians to ensure success.
About Accelitech LLC
Accelitech LLC is a leading developer of stereotactic radiosurgery and cancer programs. Headquartered in Chicago, Accelitech is a privately held company with broad experiences and resources in healthcare law, finance, development, and clinical operations. Accelitech provides the capital, expertise and legal models to allow physicians and hospitals to bring new technology to market for the benefit of the patients they serve. Accelitech has sites and projects under development throughout the United States.